This inventor holds 2 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: 858 Therapeutics, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Innovations of James M Veal
Introduction
James M Veal is an accomplished inventor based in Solana Beach, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for PARG. With a total of 2 patents, his work is recognized for its potential impact on disease treatment.
Latest Patents
James M Veal's latest patents include "Substituted imidazo[1,2-A]quinazolines as inhibitors of PARG" and "Substituted imidazo[1,2-a]quinazolines and imidazo [1,2-a]pyrido[4,3-e]pyrimidines as inhibitors of PARG." These patents provide innovative pharmaceutical compositions comprising the inhibitory compounds and methods for using them in the treatment of various diseases. The inhibitors of PARG are characterized by specific structures outlined in the patents.
Career Highlights
James M Veal is currently associated with 858 Therapeutics, Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in therapeutic settings.
Collaborations
James has collaborated with notable colleagues, including Jeffrey A Stafford and Donald Karanewsky, contributing to a dynamic research environment that fosters innovation.
Conclusion
James M Veal's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile